Are you experiencing significant weight loss yet
K., Plutzky, J., van Beek, A
Research Use Only : This product is sold strictly for research purposes and is not intended for human consumption, therapeutic use, or veterinary applications
Similarly, while bio-electrochemical systems such as MFCs and MECs remain limited by low efficiency and technological maturity, emerging ammonia recovery processes present a promising carbon-free energy pathway, though their deployment demands advanced infrastructure and stringent control of NO x emissions
Once you have your diagnosis, mapping out the next steps with your clinician is key
In September 2025, the FDA granted accelerated approval to elamipretide (under the brand name FORZINITY) for Barth syndrome, making it the first FDA-approved mitochondria-targeted therapy